Results

Total Results: 460 records

Showing results for "vascular".

161. Outcomes of Angiotensin-converting Enzyme Inhibitor (ACEI) Use During Pregnancy | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/pregnancy-acei-outcomes/abstract
     April 14, 2010 - Outcomes of Angiotensin-converting Enzyme Inhibitor (ACEI) Use During Pregnancy Research Report April 14, 2010 Findings from this study were published in the following journal article. Li D, Yang C, Andrade S, et al. Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester …

162. A Multicenter, Observational Cohort Study to Assess the Cardiovascular Risks of Medications Prescribed for Attention Deficit Hyperactivity Disorder | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/adhd-medicines-risks/abstract
     January 01, 2005 - A Multicenter, Observational Cohort Study to Assess the Cardiovascular Risks of Medications Prescribed for Attention Deficit Hyperactivity Disorder Abstract Archived January 1, 2005 Topic Abstract Attention-Deficit/Hyperactivity Disorder (ADHD) is a syndrome that includes poor concentration, hyperact…

163. Comparative Effectiveness of Approaches to Weight Maintenance in Adults | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/weight-gain-prevention/research-protocol
     October 25, 2011 - Current Page Topic Timeline Jun. 15, 2011 Topic Initiated Oct. 25, 2011 Research Protocol Mar. 25, 2013 Systematic Review Jul. 26, 2013 Disposition of Comments Report Comparative Effectiveness of Approaches to Weight Maintenance in Adults Research Protocol Archived October 25, 2011 Download Main Document PDF 446.5…

164. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
     January 01, 2016 - The total incidence of deaths from vascular or unknown causes, nonfatal myocardial infarctions, and … nonfatal cerebrovascular accidents, which are possible effects from systemic vascular endothelial … The incidence of serious adverse events potentially related to systemic vascular endothelial growth … Vascular endothelial growth factor A. In: GeneCards [internet]. … Clinical policy bulletin: vascular endothelial growth factor inhibitors for ocular neovascularization

165. Self-Measured Blood Pressure Monitoring | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/measuring-blood-pressure/research-protocol
     April 11, 2011 - events (myocardial infarction, new-onset angina, stroke, transient ischemic attack, and peripheral vascular

166. Comparative Effectiveness of Management Strategies for Renal Artery Stenosis | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/renal-artery-stenosis/research
     October 24, 2006 - Current Page Topic Timeline Jan. 1, 2005 Topic Initiated Nov. 19, 2007 Systematic Review Jun. 13, 2013 Surveillance Report Comparative Effectiveness of Management Strategies for Renal Artery Stenosis Systematic Review Archived October 24, 2006 Web Version [NLM Site] Download Main Document PDF 1.8 MB …

167. Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients With Kidney Disease | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/renal-function/research
     August 11, 2014 - Current Page Topic Timeline Jun. 17, 2008 Topic Suggestion Jun. 13, 2013 Research Protocol Aug. 11, 2014 Systematic Review Nov. 24, 2014 Disposition of Comments Report Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients With Kidney Disease Systematic Review Archived August 11, 2014 Web Version [N…

168. Comparative Effectiveness of Antihypertensive Therapies on Cardiovascular Disease Outcomes In End-Stage Renal Disease | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/renal-disease-therapies/abstract
     March 31, 2011 - Comparative Effectiveness of Antihypertensive Therapies on Cardiovascular Disease Outcomes In End-Stage Renal Disease Abstract Archived March 31, 2011 Topic Abstract Background : The optimal antihypertensive therapeutic regimen to improve cardiovascular disease (CVD)-related morbidity and mortality a…

169. Pharmacologic and Mechanical Prophylaxis of Venous Thromboembolism Among Special Populations | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/vte-prophyalaxis/research
     May 29, 2013 - Current Page Topic Timeline Aug. 16, 2011 Topic Initiated Jan. 12, 2012 Research Protocol May. 29, 2013 Systematic Review Sep. 12, 2013 Disposition of Comments Report Pharmacologic and Mechanical Prophylaxis of Venous Thromboembolism Among Special Populations Systematic Review Archived May 29, 2013 Web Version [NL…

170. Enzyme Replacement Therapy for Lysosomal Storage Disorders | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/lysosomal-storage-diseases-therapies/research-protocol
     October 05, 2011 - Current Page Topic Timeline Oct. 4, 2011 Topic Initiated Oct. 5, 2011 Research Protocol Jan. 2, 2013 Technical Brief May. 2, 2013 Disposition of Comments Report Enzyme Replacement Therapy for Lysosomal Storage Disorders Research Protocol Archived October 5, 2011 Download Main Document PDF 123 KB On A…

171. Arteriovenous Malformations | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/arteriovenous-malformations

172. Cer-250-Cannabis-Table-E5-2022-Update 0 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-table-e5-2022-update_0.xlsx
     January 01, 2022 - 0.32 to 0.71) Psychiatric disorders: 4.2% (14/337) vs. 14.8% (50/337), RR 0.28 (95% CI 0.16 to 0.50) Vascular

173. Intravascular Diagnostic Procedures and Imaging Techniques Versus Angiography Alone in Coronary Stenting: Future Research Needs | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/coronary-artery-stenting-future/research

174. Diabetes Medications for Adults with Type 2 Diabetes: An Update Focused on Monotherapy and Add-on Therapy to Metformin | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/diabetes-update-2015/research-protocol
     January 22, 2015 - Current Page Topic Timeline Jan. 20, 2015 Topic Initiated Jan. 22, 2015 Research Protocol Apr. 19, 2016 Systematic Review Diabetes Medications for Adults with Type 2 Diabetes: An Update Focused on Monotherapy and Add-on Therapy to Metformin Research Protocol Archived January 22, 2015 Download Main Document PDF 1.6…

175. Effectiveness of Isosorbide Dinitrate and Hydralazine in Racial/Ethnic Subgroups With Heart Failure | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/congestive-heart-failure-medicines/research
     March 31, 2010 - disease, Liver disease, AIDS/HIV, Lymphoma, Solid tumor without metastases, Rheumatoid arthritis/collagen vascular … (Quan 13 modification of Elixhauser 30 ) Cardiac arrhythmias 28.1% 24 <.0001 Peripheral vascular

176. Vitamin-D-Calcium-Protocol-130611 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/vitamin-d-calcium_research-protocol.pdf
     September 13, 2013 - o CVD clinical outcomes  Cardiac events or symptoms  Cerebrovascular events  Peripheral vascular … myocardial infarction, angina]; cerebrovascular events [stroke; transient ischemic attacks]; peripheral vascular

177. Anticoagulation for Venous Thromboembolic Events in Patients with Cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cancer-venous-thrombosis-anticoagulation/abstract
     December 15, 2009 - Anticoagulation for Venous Thromboembolic Events in Patients with Cancer Abstract Archived December 15, 2009 Topic Abstract Background: People with advanced cancer are at high risk for venous thromboembolic events (VTE). Trial data suggests that low molecular weight heparins (LMWH) may decrease recu…

178. Serum-Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/plasma-cell-dyscrasias-sflc-assay/research-protocol
     May 02, 2011 - Current Page Topic Timeline Jun. 17, 2009 Topic Suggestion May. 2, 2011 Research Protocol Aug. 23, 2012 Systematic Review Jun. 28, 2013 Disposition of Comments Report Serum-Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias Research Protocol Archived May 2, 2011 Downlo…

179. Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias: Future Research Needs | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/plasma-cell-dyscrasias-sflc-assay-future/research

180. ADHD Medications and Risk of Serious Coronary Heart Disease in Yough and Middle-Aged Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-children_research.pdf
     January 01, 2023 - or transient ischemic attack, congenital heart disorder, coronary artery anomaly, and peripheral vascular … Age-specific relevance of usual blood pressure to vascular mortality: a meta- analysis of individual … Congenital heart disorder 331 0.2% 556 0.2% Coronary artery anomaly 66 0.0% 89 0.0% Peripheral vascular … 849.5 1.1% Coronary artery anomaly 16.3 0.2% 7.6 0.1% 14.4 0.2% 79.3 0.4% 154.9 0.2% Peripheral vascular … 3798.7 20 5.27 1.02 0.65-1.60 Coronary artery anomaly 656.6 14 21.32 1.58 0.92-2.70 Peripheral vascular